Squeeze Report — September 2, 2026
Biotech dominates today's high-conviction squeeze candidates, with FDA decisions and Phase 3 readouts clustering as the catalysts most likely to force covering. Outside the sector, GRRR's 26.85% borrow fee and CRK's $1.65B asset sale stand out as the only non-biotech setups with real teeth.
Today's top short-squeeze candidates
- #1SLDBSolid Biosciences Inc. Common82
21% of float sold short · 19.6 days to cover · +15% over 20 days · options pricing in the 97th percentile (crowded)
SI 21%DTC 19.6$9.88+15% 20dHealthcare - #2GRRRGorilla Technology Group Inc.81
Borrow fees spiked to 26.85% with 600 shares available, but fraud allegations and 22.1M shares of resale registration loom.
SI 40%DTC 5.2$14.09+15% 20dTechnology - #3MMEDMiniMed Group, Inc. Common Sto79
21% of float sold short · 5.7 days to cover · +18% over 20 days
SI 21%DTC 5.7$22.42+18% 20dHealthcare - #4VERAVera Therapeutics, Inc. Class79
29% of float sold short · 7.0 days to cover · +14% over 20 days
SI 29%DTC 7.0$34.23+14% 20dHealthcare - #5CELCCelcuity Inc. Common Stock78
35% of float sold short · 13.2 days to cover · -1% over 20 days
SI 35%DTC 13.2$91.98-1% 20dHealthcare - #6TGTXTG Therapeutics, Inc. Common S78
22% of float sold short · 12.6 days to cover · +15% over 20 days
SI 22%DTC 12.6$56.09+15% 20dHealthcare - #7SPRYARS Pharmaceuticals, Inc. Comm78
35.6% short interest meets going-concern language and a $123M H1 loss; the catalyst needs to arrive before dilution does.
SI 36%DTC 11.0$5.77+8% 20dHealthcare - #8CRKComstock Resources, Inc.77
A $1.65B SOCAR asset sale and Jerry Jones JV could force covering, but 0.3% borrow means shorts aren't paying to wait.
SI 31%DTC 13.4$16.02+20% 20dEnergy - #9BHVNBiohaven Ltd.77
BlackRock's new 8.77% stake and October RISE3 data give shorts a reason to cover before the readout.
SI 14%DTC 10.3$15.74+14% 20dHealthcare - #10CNXCConcentrix Corporation Common76
A 26.6% bounce off the low meets 10.56 days to cover, yet options are pricing almost no event risk.
SI 23%DTC 10.6$32.28+27% 20dTechnology - #11PRGOPERRIGO COMPANY PLC76
16% of float sold short · 6.9 days to cover · +34% over 20 days
SI 16%DTC 6.9$14.43+34% 20dHealthcare - #12PEGAPegasystems Inc. Common Stock75
13% of float sold short · 7.4 days to cover · +16% over 20 days
SI 13%DTC 7.4$36.68+16% 20dTechnology - #13DUOLDuolingo, Inc. Class A Common75
17.8% short interest and a $329.7M buyback are real, but heavy insider selling plans and a cooling group mute conviction.
SI 18%DTC 4.5$158.77+15% 20dTechnology - #14IBRXImmunityBio, Inc. Common Stock75
112% of float sold short · 15.4 days to cover · +13% over 20 days
SI 112%DTC 15.4$7.87+13% 20dHealthcare - #15IMMXImmix Biopharma, Inc. Common S75
The +50.2% 20-day run likely already flushed the shorts; what's left is dilution and fraud investigations.
SI 24%DTC 7.0$14.01+50% 20dHealthcare
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →